全文获取类型
收费全文 | 1197篇 |
免费 | 46篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 35篇 |
妇产科学 | 11篇 |
基础医学 | 112篇 |
口腔科学 | 10篇 |
临床医学 | 75篇 |
内科学 | 132篇 |
皮肤病学 | 233篇 |
神经病学 | 16篇 |
特种医学 | 99篇 |
外科学 | 117篇 |
综合类 | 264篇 |
预防医学 | 35篇 |
眼科学 | 5篇 |
药学 | 43篇 |
肿瘤学 | 61篇 |
出版年
2023年 | 1篇 |
2022年 | 3篇 |
2021年 | 8篇 |
2020年 | 7篇 |
2019年 | 16篇 |
2018年 | 12篇 |
2017年 | 17篇 |
2016年 | 13篇 |
2015年 | 31篇 |
2014年 | 19篇 |
2013年 | 21篇 |
2012年 | 43篇 |
2011年 | 25篇 |
2010年 | 53篇 |
2009年 | 47篇 |
2008年 | 50篇 |
2007年 | 63篇 |
2006年 | 79篇 |
2005年 | 60篇 |
2004年 | 81篇 |
2003年 | 47篇 |
2002年 | 57篇 |
2001年 | 36篇 |
2000年 | 31篇 |
1999年 | 43篇 |
1998年 | 50篇 |
1997年 | 53篇 |
1996年 | 54篇 |
1995年 | 35篇 |
1994年 | 31篇 |
1993年 | 11篇 |
1992年 | 19篇 |
1991年 | 17篇 |
1990年 | 10篇 |
1989年 | 10篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 11篇 |
1985年 | 7篇 |
1984年 | 12篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
排序方式: 共有1253条查询结果,搜索用时 15 毫秒
81.
P?KumarEmail author S?Reddy D?Kulkarni C?Raghvendra SK?Pranav N?Thakur U?Jadhav A?Tendolkar 《Indian Journal of Thoracic and Cardiovascular Surgery》2003,19(3):155-156
Conclusion The use of a pulse oximeter, which is readily available in the ICU, can be of immense benefit to determine the status of distal
limb perfusion in neonates and children who are suspected of having a vascular compromise, and the pulsations cannot be appreciated
due to the presence of limb edema.
Limb warmth and capillary filling are the primary indicators of vascularity but may be misleading in some patients. The presence
of poor quality tracings or absent tracings is a definite indicator of significant ischemia.
The use of a pulse oximeter, for determination of oxygen saturation, was declared by Severinghaus and Astrup to be “arguably
the most significant technologic advance ever made in monitoring the well being of patients during anaesthesia, recovery and
critical care. Perhaps the use of the pulse oximeter for determination of distal perfusion can further augment the statement.
Editor Note The authors are to be congratulated for their observations which are clinically relevant. However we urge them to continue
their study and obtain meaningful data, with proper statistical analysis. For the time being these observations may be considered
preliminary. 相似文献
82.
Evidence for endogenous interleukin-10 during nociception 总被引:3,自引:0,他引:3
83.
Surendran S Rady PL Michals-Matalon K Quast MJ Rassin DK Campbell GA Ezell EL Wei J Tyring SK Szucs S Matalon R 《Brain research bulletin》2003,61(4):427-435
Canavan disease (CD) is an autosomal recessive leukodystrophy characterized by spongy degeneration of the brain. The clinical features of CD are hypotonia, megalencephaly, and mental retardation leading to early death. While aspartoacylase (ASPA) activity increases with age in the wild type mouse brain, there is no ASPA activity in the CD mouse brain. So far ASPA deficiency and elevated NAA have been ascribed with the CD. Other factors affecting the brain that result from ASPA deficiency may lead pathophysiology of CD. The NMR spectra and amino acid analysis showed lower levels of glutamate and gamma-aminobutyric acid in the CD mouse brain compared to the wild type. Microarray gene expression on CD mouse brain showed glutamate transporter-EAAT4 and gamma-aminobutyric acid-A receptor, subunit alpha6 (GABRA6) were lower 9.7- and 119.1-fold, respectively. Serine proteinase inhibitor 2 (Spi2) was 29.9-fold higher in the CD mouse brain compared to the wild type. The decrease of GABRA6 and high expression of Spi2 in CD mouse brain were also confirmed by real-time RT-PCR. This first report showing abnormal expression of EAAT4, GABRA6, Spi2 combined with lower levels of glutamate and GABA are likely to be associated with the pathophysiology of CD. 相似文献
84.
Tyring S Belanger R Bezwoda W Ljungman P Boon R Saltzman RL;Colaborative Famciclovir Immunocompromised Study Group 《Cancer investigation》2001,19(1):13-22
In this randomized, double-blind, multicenter, acyclovir-controlled study, the efficacy and safety of famciclovir were evaluated for the treatment of herpes zoster in patients who were immunocompromised following bone marrow or solid organ transplantation or oncology treatment. A total of 148 patients, 12 years or older with clinical evidence of localized herpes zoster, received either oral famciclovir, 500 mg three times daily, or acyclovir, 800 mg five times daily, for 10 days. Famciclovir was equivalent to acyclovir with respect to the numbers of patients reporting new lesion formation while on therapy (77% vs. 73%, respectively). There were no significant differences between the groups in the time to cessation of new lesion formation, full crusting, complete healing of lesions, or loss of acute phase pain. Treatment with famciclovir was well tolerated, with a safety profile comparable to that of acyclovir. Thus oral famciclovir is a convenient, effective, and well-tolerated regimen for immunocompromised patients with herpes zoster. 相似文献
85.
The rates of herpes simplex virus (HSV) infection are rising, the highest prevalence being in the group infected with the human immunodeficiency virus (HIV). We review the relation between these 2 infections. The presence of genital ulcers increases the transmission of HIV, and the presence of HIV adversely affects the natural history of HSV infection. The detection and treatment of sexually transmitted diseases such as genital herpes actually decrease the rates of HIV infection in groups studied. The treatment of HSV in persons with HIV is challenging because the incidence of immunosuppression increases. Acyclovir resistance is more common in this group, but acyclovir use may prolong survival in some HIV-seropositive patients. Further studies are needed to determine whether persons with HIV disease should routinely be given HSV-specific therapy. 相似文献
86.
SK. Das A Bhowmick S. Mukherjee L. M. Ghosh S. Banerjee 《Indian journal of otolaryngology and head and neck surgery》1999,51(3):66-68
Dentigerous cyst - a cyst of dental origin, though common in lower jaw is relatively uncommon in upper jaw. Here a 14 years, F, presented with huge swelling of unilateral maxilla and clinicoradiologically diagnosed as dentigerous cyst is being reported along with brief review of literature. 相似文献
87.
L Corey A G Langenberg R Ashley R E Sekulovich A E Izu J M Douglas H H Handsfield T Warren L Marr S Tyring R DiCarlo A A Adimora P Leone C L Dekker R L Burke W P Leong S E Straus 《JAMA》1999,282(4):331-340
CONTEXT: In the last 3 decades, herpes simplex virus type 2 (HSV-2) infection seroprevalence and neonatal herpes have increased substantially. An effective vaccine for the prevention of genital herpes could help control this epidemic. OBJECTIVE: To evaluate the efficacy of a vaccine for prevention of HSV-2 infection. DESIGN: Two randomized, double-blind, placebo-controlled multicenter trials of a recombinant subunit vaccine containing 30 microg each of 2 major HSV-2 surface glycoproteins (gB2 and gD2) against which neutralizing antibodies are directed, administered at months 0, 1, and 6. Control subjects were given a citrate buffer vehicle. Participants were followed up for 1 year after the third immunization. SETTING AND PARTICIPANTS: We enrolled 2393 persons from December 10, 1993, to April 4, 1995, who were HSV-2 and human immunodeficiency virus seronegative. One trial with 18 centers enrolled 531 HSV-2-seronegative partners of HSV-2-infected persons; the other, with 22 centers, enrolled 1862 persons attending sexually transmitted disease clinics. A total of 2268 (94.8%) met inclusion criteria and were included in the analysis with 1135 randomized to placebo and 2012 to vaccine. MAIN OUTCOME MEASURE: Time to acquisition of HSV-2 infection, defined by seroconversion or isolation of HSV-2 in culture during the study period by randomization group. RESULTS: Time-to-event curves indicated a 50% lower acquisition rate among vaccine vs placebo recipients during the initial 5 months of the trial; however, overall vaccine efficacy was 9% (95% confidence interval, -29% to 36%). Acquisition rates of HSV-2 were 4.6 and 4.2 per 100 patient-years in the placebo and vaccine recipients, respectively (P =.58). Follow-up of vaccine recipients acquiring HSV-2 infection showed vaccination had no significant influence on duration of clinical first genital HSV-2 episodes (vaccine, median of 7.1 days; placebo, 6.5 days; P>.10) or subsequent frequency of reactivation (median monthly recurrence rate with vaccine, 0.2; with placebo, 0.3; P>.10). The vaccine induced high levels of HSV-2-specific neutralizing antibodies in vaccinated persons who did and did not develop genital herpes. CONCLUSIONS: Efficient and sustained protection from sexual acquisition of HSV-2 infection will require more than high titers of specific neutralizing antibodies. Protection against sexually transmitted viruses involving exposure over a prolonged period will require a higher degree of vaccine efficacy than that achieved in this study. 相似文献
88.
89.
Sierra-Torres CH Au WW Arrastia CD Cajas-Salazar N Robazetti SC Payne DA Tyring SK 《Environmental and molecular mutagenesis》2003,41(1):69-76
Infection with high-risk human papillomavirus (HPV) plays a major role in the etiology of cervical cancer (CC). However, most infected women do not develop cancer. Therefore, exposure to other carcinogenic agents may be a contributing risk factor for CC. We investigated the hypothesis that environmental exposure to cigarette smoke and inheritance of polymorphic chemical metabolizing genes (CYP2E1, GSTM1, and mEH) significantly increase the risk for neoplasia. We selected 76 cases with high-grade cervical neoplasia or with invasive CC and 75 matched healthy controls. The collected data support the well-established observation that infection with high-risk HPV is the major risk factor for CC (OR = 75; 95% CI = 26-220). In addition, our data show that women who smoked more than 15 "pack-year" had a significant 6.9-fold increase in risk (95% CI = 1.2-40.3) after adjustment for HPV infection. The CYP2E1 variant genotype did not significantly increase the risk for neoplasia. A significant increase in risk for neoplasia was observed for the low-activity mEH 113 His allele after adjustment for smoking (OR = 3.0; 95% CI = 1.4-6.3). The GSTM1 null genotype was associated with a significant 3.3-fold increased risk for neoplasia (95% CI = 1.0-11.8) compared to women who were GSTM1-positive after adjustment for smoking and HPV infection. Our study suggests that genetic differences in the metabolism of cigarette smoke, particularly GSTM1, may confer susceptibility to CC. Further studies using larger populations will be needed to confirm our observations and to validate data for disease prevention. 相似文献
90.